Literature DB >> 9150470

Effects of sex hormones on fluid and solute transport in Madin-Darby canine kidney cells.

S Sandhu1, S R Silbiger, J Lei, J Neugarten.   

Abstract

Polycystic kidney disease progresses more rapidly in men than in women. To investigate the basis for this sexual dimorphism, we exposed Madin-Darby canine kidney (MDCK) cells grown on collagen-coated cell culture inserts to control media, or to estradiol or testosterone (1 nM-1 microM). Compared to control and estradiol-treated cells, testosterone stimulated fluid secretion in a dose-dependent manner, enhancing fluid secretion 4.8-fold at 1 nM and 19.7-fold at 1 microM (0.59 +/- 0.18 vs. 0.03 +/- 0.01 microliter/cm2/hr, P < 0.001). Chloride transport paralleled fluid secretion. Testosterone increased cellular cyclic AMP levels 3.2-fold at 1 nM and 12.3-fold at 1 microM (81.3 +/- 30.7 vs. 6.6 +/- 3.3 pmol/mg protein, P < 0.001). GDP beta S (500 microM), an inhibitor of Gs, and 2',3'-dideoxyadenosine (10 microM), an inhibitor of the catalytic subunit of adenylate cyclase, suppressed testosterone-induced fluid and solute secretion. Neither testosterone nor estradiol had any effect on microsomal Na,K-ATPase activity, cellular proliferation or cellular total protein content. Our studies show that testosterone stimulates fluid secretion and solute transport by MDCK cells by increasing cAMP generation. In vivo, testosterone may contribute to cyst expansion by enhancing fluid secretion. This observation may help explain the worse prognosis of polycystic kidney disease observed in men.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9150470     DOI: 10.1038/ki.1997.211

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  5 in total

1.  Changes of endogenous erythropoietin level and iron status during a 30-month hemodialysis treatment of a group of patients.

Authors:  M Majdan; A Ksiazek; A Bednarek-Skublewska; D Spasiewicz
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

2.  Determinants of renal volume in autosomal-dominant polycystic kidney disease.

Authors:  J J Grantham; L T Cook; V E Torres; J E Bost; A B Chapman; P C Harris; L M Guay-Woodford; K T Bae
Journal:  Kidney Int       Date:  2007-10-24       Impact factor: 10.612

Review 3.  Gender differences in kidney function.

Authors:  Ivan Sabolić; Abdul R Asif; Wolfgang E Budach; Christoph Wanke; Andrew Bahn; Gerhard Burckhardt
Journal:  Pflugers Arch       Date:  2007-07-19       Impact factor: 3.657

4.  Characteristics of Patients with End-Stage Kidney Disease in ADPKD.

Authors:  Shehbaz S Shukoor; Lisa E Vaughan; Marie E Edwards; Sravanthi Lavu; Timothy L Kline; Sarah R Senum; Yaman Mkhaimer; Ghaith Zaatari; Maria V Irazabal; Reem Neal; Marie C Hogan; Ziad M Zoghby; Peter C Harris; Vicente E Torres; Fouad T Chebib
Journal:  Kidney Int Rep       Date:  2020-12-31

5.  Long-Term Outcomes of Longitudinal Efficacy Study With Tolvaptan in ADPKD.

Authors:  Eiji Higashihara; Kikuo Nutahara; Masayuki Itoh; Takatsugu Okegawa; Mistuhiro Tambo; Tsuyoshi Yamaguchi; Yu Nakamura; Satoru Taguchi; Shinya Kaname; Kenichi Yokoyama; Tatsuya Yoshioka; Hiroshi Fukuhara
Journal:  Kidney Int Rep       Date:  2021-12-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.